B-lymphocyte

(redirected from B-lymphocytes)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to B-lymphocytes: Plasma B cells

B lymphocyte

also B-lym·pho·cyte  (bē′lĭm′fə-sīt′)
n.
See B cell.

B-lymphocyte

n
(Biochemistry) a type of lymphocyte, originating in bone marrow, that produces antibodies. Also called: B-cell See also T-lymphocyte
Mentioned in ?
References in periodicals archive ?
Ublituximab (TG-1101) is a novel, glycoengineered monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes. TG Therapeutics is also developing umbralisib (TGR-1202), an oral, once-daily inhibitor of PI3K-delta.
B-lymphocytes (CD 10+ and CD 19+) are sensitive to glucocorticoids.
To characterize the inflammatory cell populations in animals with terminal disease, we conducted IHC staining targeting CD3+ T-lymphocytes and CD79a+ B-lymphocytes. The composition of inflammatory cells varied based on disease duration.
There are more than 60 subtypes of non-Hodgkin lymphomas which are broadly divided into two major groups: B-cell lymphomas, which develop from abnormal B-lymphocytes, and T-cell lymphomas, which develop from abnormal T-lymphocytes.
The objective of this study was to determine whether plasma levels of APRIL can be used to assess the proliferation of B-lymphocytes in patients with bacterial infections, B-cell malignancies and autoimmune inflammatory disorders.
These antigens are then attacked by antibodies which are produced by B-lymphocytes.
Antibodies are proteins of the immune system that are produced by B-lymphocytes. These proteins exert their effects by recognizing and binding to their targets (antigens).
The B-lymphocytes make billions of different types of antibody receptors (B-cells) capable of binding specific antigens and marking them for death.
The study strongly conveys that osteoclastic properties of PMT has been a result of cross talk between cell-signalling pathways between osteoblasts and B-Lymphocytes, the susceptible object for P.
Most of these cells were EBER positive (Figure 2(c)); B-lymphocytes (CD20+, PAX-5+) were almost absent while there was an expansion of the monocytemacrophage series (CD14+, CD64+).
EBV infects B-lymphocytes via the EBV receptor known as CD21 or Complement Receptor 2 (CR2).
The histological study revealed a polymorphic cellular infiltrate with histiocytes, CD3+ T-lymphocytes, and CD 20+ B-lymphocytes (mixture of numerous small cells and large activated cells with positive hybridization results for EBV-encoded RNA (EBER)).